Core Scientific investors expected to resist merger with CoreWeave

Core Scientific shareholders are reportedly opposed to the terms CoreWeave has proposed for its acquisition of the company, arguing that the $9 billion deal does not reflect the company’s true value and puts them at a disadvantage. The Financial Times…








